A phase II study of dual immune checkpoint blockade (ICB) plus androgen receptor (AR) blockade to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Page, D. B.; Kim, I. K.; Chun, B.; Redmond, W. L.; Martel, M.; Mori, M.; Wadell, D.; Moxon, N.; Mellinger, S. L.; Urba, W. J.; Gucalp, A.; Traina, T. A. |
| Abstract Title: | A phase II study of dual immune checkpoint blockade (ICB) plus androgen receptor (AR) blockade to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 60s |
| Language: | English |
| ACCESSION: | WOS:000487345803226 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS1106 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS1106 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work